Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial.
Am Heart J. 2021 Jan;231:128-136. doi: 10.1016/j.ahj.2020.10.001. Epub 2020 Oct 10.
Am Heart J. 2021.
PMID: 33045224
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
Guimarães HP, Lopes RD, de Barros E Silva PGM, Liporace IL, Sampaio RO, Tarasoutchi F, Hoffmann-Filho CR, de Lemos Soares Patriota R, Leiria TLL, Lamprea D, Precoma DB, Atik FA, Silveira FS, Farias FR, Barreto DO, Almeida AP, Zilli AC, de Souza Neto JD, Cavalcante MA, Figueira FAMS, Kojima FCS, Damiani L, Santos RHN, Valeis N, Campos VB, Saraiva JFK, Fonseca FH, Pinto IM, Magalhães CC, Ferreira JFM, Alexander JH, Pavanello R, Cavalcanti AB, Berwanger O; RIVER Trial Investigators.
Guimarães HP, et al.
N Engl J Med. 2020 Nov 26;383(22):2117-2126. doi: 10.1056/NEJMoa2029603. Epub 2020 Nov 14.
N Engl J Med. 2020.
PMID: 33196155
Clinical Trial.
Item in Clipboard
Increased expression of tumor necrosis factor-alpha in diabetic macrovasculopathy.
Clausell N, Kalil P, Biolo A, Molossi S, Azevedo M.
Clausell N, et al.
Cardiovasc Pathol. 1999 May-Jun;8(3):145-51. doi: 10.1016/s1054-8807(98)00033-7.
Cardiovasc Pathol. 1999.
PMID: 10722237
Clinical Trial.
Item in Clipboard
Cite
Cite